Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy

Everson GT, Trotter J, Forman L, Kugelmas M, Halprin A, Fey B, et al. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology. 2005;42(2):255-262.

Publication Type:

Journal Article

Authors:

G.T. Everson; Trotter, J.; Forman, L.; Kugelmas, M.; Halprin, A.; Fey, B.; Ray, C.

Source:

Hepatology, Volume 42, Issue 2, p.255-262 (2005)

Keywords:

administration & dosage, Adult, adverse effects, Aged, analysis, Antiviral Agents, Ascites, blood, CLASS, classification, Colorado, complications, Death, Disease, drug therapy, Female, Gastroenterology, genetics, Genotype, genotype 1, HCV, Hemorrhage, Hepacivirus, hepatitis, Hepatitis C, hepatitis C virus, Hepatitis C,Chronic, Humans, interferon, Interferon Alfa-2b, Interferon-alpha, Liver, Liver Transplantation, Male, Medicine, Middle Aged, Patients, Peritonitis, Proteins, Recombinant Proteins, Recurrence, Ribavirin, Risk, Rna, Rna,Viral, SVR, therapy, transplantation, treatment, virology

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/16025497

Export Citation:

RIS Format

Top